InMode Ltd. (INMD) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$13.59
Price Target
$16.00
Target Range
$15.00 — $17.00
Analyst Rating
Buy
Forward P/E9.4x
Trailing P/E9.5x
Forward PEG0.95
Implied Growth-1.3%
Median Target$16.00
Analyst Spread12.5%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$15
+10.4%
Consensus
$16
+17.7%
Bull Case
$17
+25.1%
Valuation Model TargetsConfidence: 45/100
Bear$3
Base$16
Bull$63
INMD Price Target Analysis
Updated May 7, 2026As of May 7, 2026, InMode Ltd. (INMD) has a Wall Street consensus price target of $16.00, based on estimates from 11 covering analysts. With the stock currently trading at $13.59, this represents a potential upside of +17.7%. The company has a market capitalization of $861M.
Analyst price targets range from a low of $15.00 to a high of $17.00, representing a 13% spread in expectations. The median target of $16.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, INMD trades at a trailing P/E of 9.5x and forward P/E of 9.4x. The forward PEG ratio of 0.95 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -1.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $16.26, with bear and bull scenarios of $3.23 and $63.12 respectively. Model confidence stands at 45/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+39.6%
Avg Forward P/E27.2x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 AEYEAudioEye, Inc. | $95M | $7.66 | — | — | — | — | — |
 STAASTAAR Surgical Company | $1.4B | $27.75 | $22.95 | -17.3% | Hold | 71.4x | 15 |
 NVCRNovoCure Limited | $1.9B | $16.50 | $33.50 | +103.1% | Buy | — | 15 |
 ISRGIntuitive Surgical, Inc. | $160.4B | $451.73 | $622.60 | +37.8% | Buy | 43.7x | 55 |
 GMEDGlobus Medical, Inc. | $12.1B | $89.22 | $110.67 | +24.0% | Buy | 20.0x | 36 |
 LNTHLantheus Holdings, Inc. | $5.6B | $86.15 | $101.00 | +17.2% | Buy | 16.6x | 17 |
 ABTAbbott Laboratories | $150.0B | $86.25 | $128.71 | +49.2% | Buy | 15.7x | 41 |
 MDTMedtronic plc | $99.5B | $77.60 | $109.50 | +41.1% | Buy | 14.1x | 49 |
 BSXBoston Scientific Corporation | $83.2B | $56.00 | $91.33 | +63.1% | Buy | 16.6x | 43 |
 SYKStryker Corporation | $112.0B | $292.33 | $403.69 | +38.1% | Buy | 19.5x | 50 |
Upside Potential Comparison
NVCRBSXABTMDTSYKISRGGMEDLNTHSee INMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs INMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare INMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonINMD — Frequently Asked Questions
Quick answers to the most common questions about buying INMD stock.
What is the INMD stock price target for 2026?
InMode Ltd. (INMD) has a consensus 12-month price target of $16, implying 17.7% upside from $13.59. The 11 analysts covering INMD see moderate appreciation potential.
Is INMD a buy, sell, or hold?
INMD has a consensus rating of "Buy" based on 11 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $16 implies 17.7% upside from current levels.
Is INMD stock overvalued or undervalued?
With a forward P/E of 9.4068x, INMD trades at a relatively low valuation. The consensus target of $16 implies 17.7% appreciation, suggesting meaningful undervaluation.
How high can INMD stock go?
The most bullish Wall Street analyst has a price target of $17 for INMD, while the most conservative target is $15. The consensus of $16 represents the median expectation. Our quantitative valuation model projects a bull case target of $63 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover INMD stock?
INMD is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the INMD stock forecast?
The 12-month INMD stock forecast based on 11 Wall Street analysts shows a consensus price target of $16, with estimates ranging from $15 (bear case) to $17 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $16, with bear/bull scenarios of $3/$63.
What is INMD's fair value based on fundamentals?
Our quantitative valuation model calculates INMD's fair value at $16 (base case), with a bear case of $3 and bull case of $63. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 45/100.
What is INMD's forward P/E ratio?
INMD trades at a forward P/E ratio of 9.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 9.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy INMD stock?
Wall Street analysts are optimistic on INMD, with a "Buy" consensus rating and $16 price target (17.7% upside). 6 of 11 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do INMD price targets vary so much?
INMD analyst price targets range from $15 to $17, a 13% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $16 consensus represents the middle ground. Our model's $3-$63 range provides an independent fundamental perspective.